Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Biotech Firestorm Takes Down Novavax Despite Quadrupled Sales

Novavax posted an unexpected third-quarter loss, and NVAX stock yo-yoed Wednesday despite better-than-expected sales.

Investors Business Daily

How Amgen Is Closing In On Rivals Novo Nordisk, Eli Lilly With Obesity Drug

Amgen stock jumped Tuesday on a promising update for its potential rival to obesity treatments from Novo Nordisk and Eli Lilly.

Investors Business Daily

Breakthrough Covid drug for vulnerable proven to save lives - but it's not free on NHS

Research suggests the drug, called Evusheld, would be 88% effective at preventing intensive care admission for people with weakened immune systems still shielding from Covid because vaccines don't work for them.

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Widening tech, biotech job cuts could jolt broader Bay Area economy: experts

SAN JOSE, Calif. — Bay Area tech and biotech companies have recently revealed plans to chop thousands of jobs, layoffs that raise the specter that these cutbacks might haunt the region’s broader economy.

Tribune News Service

Novavax says Omicron shot shows strong immune response as second booster

Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.

Reuters

Psychedelic drug research held back by UK rules and attitudes, say scientists

Active ingredient of magic mushrooms still classified as having no medical value, despite clinical success

The Guardian - UK

Omicron 'grandchildren' mean 300 Covid-19 strains now discovered across the world

The World Health Organisation (WHO) has said these are filling the gaps where Omicron was once rampant

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Pandemic greed killed 1.3 million: study

Hoarding vaccines led to 1.3 million unnecessary deaths, while rich countries wasted their shots

Salon

Uganda shortens school term by two weeks to curb Ebola

Uganda will shorten the school term by two weeks to reduce daily contact amongst students and help curb the spread of Ebola, the education minister said on Tuesday.

Reuters

Calls to expand fifth COVID vaccine rollout as ATAGI considers guidelines

Pressure is mounting on the federal government to expand access to fifth COVID vaccine doses, with a growing number of vulnerable Australians facing waning immunity at a time when case numbers across the country are expected to rise.

ABC News

Needle-free Covid vaccines could be the key to beating the virus

Mucosal vaccines are delivered in your nose or throat, as sniffable or inhalable formulation

Wales Online

Pill to prevent pre-eclampsia gets UK fast track for development

Exclusive: MHRA grants innovation passport to drug that could prevent women from developing condition

The Guardian - UK

‘Exciting’ new drug found to reduce blood pressure in patients resistant to treatment

Trial finds drug Baxdrostat to be successful in bringing down blood pressure

Evening Standard

New drug could help tackle 'untreatable' high blood pressure

Researchers said those given it during a clinical trial were found to have significantly lower blood pressure

Wales Online

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

‘Exciting’ development in tackling untreatable high blood pressure

Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed.

Investors Business Daily

Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For Covid

Veru stock skyrocketed Monday after the Food and Drug Administration posted a mixed review of its repurposed cancer drug for Covid treatment.

The Street

Krystal Biotech Needs to Feed the Goldfish in 2023

Development delays across the pipeline risks losing interest on Wall Street, which has the attention span of a goldfish.

Evening Standard

Study shows ‘significant drop’ in confidence in vaccines since start of Covid

Scientists warn Covid jab met with ‘particular hostility’ despite evidence of safety

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

BioNTech earnings drop but forecast for vaccine income grows

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier

StockNews.com

1 Stock to Buy This Week Following Its Recent Earnings Beat

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

Radio France Internationale

Uganda still struggling to tackle Ebola as the death toll passes 50

Health authorities in Uganda are struggling to contain the Ebola virus after reporting 51 deaths, including healthcare workers and 132 cases across seven districts in the country. While some government-instituted lockdowns have been put in place, the International Rescue Committee is calling for more funding to curb the spread of…

Investors Business Daily

Verve, Beam Stocks Crash After FDA Halts Plan To Test Gene Editor In People

U.S. officials halted Verve's plan to begin testing in people a gene-editing approach to high cholesterol, leading VERV stock to crash.

Investors Business Daily

BioNTech Pares Losses After Doubling Profits, Raising 2022 Guidance

BioNTech doubled third-quarter profit expectations Monday and raised its full-year outlook for Covid vaccine sales — and BNTX stock jumped.

StockNews.com

3 Biotech Stocks to Accumulate During the Bear Market

2022 has been a challenging year for investors due to the combination of inflation and a slowing economy. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals. Amgen (AMGN), Corcept Therapeutics (CORT), and Regneron (REGN) are 3 to consider.

Daily Mirror

Ebola spreads despite lockdown as death toll of killer virus passes 50

Covid-style lockdowns have been extended in Uganda with more than 50 deaths reported since the start of the outbreak.

1 … 97 98 99 100

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

329 stories

Amgen

306 stories

World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.